(1 - 10 from 12
)
Micro Interventional Devices, Inc.(TM) setzt klinischen Erfolg mit...
www.ots.at
... für die Behandlung der Trikuspidalregurgitation zu werden", erklärte Willard Hennemann, PhD, Chief Science Officer bei MID. "Wir sind stolz ...
Micro Interventional Devices completes clinical implantation of ...www.medicaldevice-network.com › news › newsmicro-int...
www.medicaldevice-network.com
MID's chief science officer Willard Hennemann said: "On Tuesday, 6 December we successfully deployed nine MIA Implants in our first patient's ...
Micro Interventional Devices, Inc.™ Announces First in Human Success...
www.wallstreet-online.de
... tricuspid annulus during a minimally invasive tricuspid repair procedure," Willard Hennemann, PhD, MID's Chief Science Officer, commented.
Micro Interventional Devices has first-in-human success with ...cardiovascularnews.com › micro-interventional-devices...
cardiovascularnews.com
... procedure,” Willard Hennemann, MID's chief science officer, comments. “A significant reduction in valve area was observed post-procedure.
sorted by relevance / date